Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Carcinoma Medullary

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Carcinoma Medullary:

Pubmed Logo
Carcinoma of the breast with medullary-like features: diagnostic challenges and relationship with BRCA1 and EZH2 functions.
This case presentation reviews the histologic distinction between pure...
18th November, 2009
Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA. Arch Pathol Lab Med. 2009 Nov;133(11):1822-5.
Persistent hypercalcitoninemia in patients with medullary thyroid cancer.
Medullary thyroid carcinoma is a highly malignant and progressive disease....
18th November, 2009
Endocrine Surgical Unit, University of Perugia, Perugia, Italy. Tumori. 2009 Jul-Aug;95(4):484-7.
Novel treatment of medullary thyroid cancer.
PURPOSE OF REVIEW: Metastatic medullary thyroid cancer (MTC) is an...
17th November, 2009
Endocrinology and Diabetes Division, Veterans Affairs Greater Los Angeles Curr Opin Endocrinol Diabetes Obes. 2009 Oct;16(5):367-72.
DOI Direct Link
Long-term outcome of "prophylactic therapy" for familial medullary thyroid cancer.
BACKGROUND: About one quarter of all medullary thyroid cancers (MTC) are...
6th November, 2009
Department of Surgery I, Charite Medical School, Campus Benjamin Franklin, Surgery. 2009 Nov;146(5):906-12. Epub 2009 Jul 15.
DOI Direct Link
Medullary thyroid carcinoma with poor differentiation and atypical radiographic pattern of metastasis.
A diagnosis of sporadic medullary thyroid carcinoma (MTC) is complicated....
30th October, 2009
Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Pathol Int. 2009 Sep;59(9):660-3.
DOI Direct Link

View more research publications.

Press Releases About Carcinoma Medullary:

BioPortfolio Logo
Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the AACR-NCI-EORTC Meeting 17th November, 2009 Oncolytics Biotech Inc.
CALGARY, Nov. 17 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced updated results from a Phase I/II U.K.
Oncolytics Biotech(R) Inc. Collaborators to Present Updated Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the AACR-NCI-EORTC Meeting 16th November, 2009 Oncolytics Biotech Inc.
CALGARY, Nov. 16 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced that a poster presentation covering updated
Bayer and Onyx Announce Nexavar Data Presentations at 60th American Association for the Study of Liver Diseases Annual Meeting 29th October, 2009 Onyx Pharmaceuticals, Inc.
-- Late Breaker #9 First-in-men Demonstration of Sorafenib Plus TACE for the Treatment of Advanced Hepatocellular Carcinoma (SOCRATES trial) -- Dr. Andreas Erhardt, Klinik fur
Jennerex, Inc. Receives EMEA Orphan Drug Designation for JX-594 for the Treatment of Hepatocellular Carcinoma 19th October, 2009 Jennerex, Inc.
SAN FRANCISCO, Oct. 19 /PRNewswire/ -- Jennerex, Inc. (San Francisco, CA and Ottawa, Ontario), a clinical stage biotherapeutics company developing a proprietary breakthrough product class of targeted
AEterna Zentaris Partner, Keryx, Presented Updated Phase 2 Data on Perifosine (KRX-0401) for the Treatment of Advanced Metastatic Renal Cell Carcinoma at 8th International Kidney Cancer Symposium in Chicago 29th September, 2009 AETERNA ZENTARIS INC.
Perifosine Continues to Demonstrate Impressive Efficacy, Safety and Tolerability in Metastatic Renal Cell Carcinoma Patients who Progressed after Failing Treatment with both a VEGF

Carcinoma Medullary Patents:

USPTO Logo
US Patent No.Title
7358263 Fused bicyclic-substituted amines as histamine-3 receptor ligands
7427605 Inhibitors of ribonucleotide reductase subunit 2 and uses thereof
7432343 Diagnostic application of mail
7456196 Bicyclic-substituted amines as histamine-3 receptor ligands
7459531 50 Human secreted proteins

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Carcinoma Medullary scientists - we have details of around 205 individuals working on Carcinoma Medullary .


This page has been viewed 286 times Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Carcinoma Medullary across BioPortfolio, or for Carcinoma Medullary Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.